DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells

Yu Hsien Lee, Hui Wen Yang, Li Chiu Yang, Ming Yi Lu, Lo Lin Tsai, Shun Fa Yang, Yu Feng Huang, Ming Yung Chou, Cheng Chia Yu, Fang Wei Hu

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Tumor-initiating cells (TICs) are defined as a specialized subset of cells with tumor-initiating capacity that can initiate tumor growth, tumor relapse and metastasis. In the present study, osteosarcoma TICs (OS-TICs) were isolated and enriched from the osteosarcoma U2OS and MG-63 cell lines using sphere formation assays and serum-depleted media. These enriched OS-TICs showed the expression of several typical cancer stemness markers, including octamer-binding transcription factor 4, Nanog homeobox, cluster of differentiation (CD)117, Nestin and CD133, and the expression of ATP binding cassette subfamily G member 2, multidrug resistance protein 1 (MDR1) and dihydrofolate reductase (DHFR). Notably, in vitro and in vivo tumorigenic properties were enhanced in these OS-TICs. Additionally, methotrexate and doxorubicin are the most widely used anticancer agents against osteosarcoma, and the observed enhanced chemoresistance of OS-TICs to these two agents could be associated with the upregulation of DHFR and MDR1. These findings suggest that the upregulation of DHFR and MDR1 is associated with the development of chemoresistance of OS-TICs.

Original languageEnglish
Pages (from-to)171-179
Number of pages9
JournalOncology Letters
Volume14
Issue number1
DOIs
Publication statusPublished - 2017
Externally publishedYes

Fingerprint

Tetrahydrofolate Dehydrogenase
P-Glycoprotein
Osteosarcoma
Up-Regulation
Stem Cells
Neoplastic Stem Cells
Octamer Transcription Factors
Nestin
Neoplasms
Homeobox Genes
Methotrexate
Antineoplastic Agents
Doxorubicin
Adenosine Triphosphate
Neoplasm Metastasis
Recurrence
Cell Line
Growth
Serum

Keywords

  • Chemo-resistance
  • Dihydrofolate reductase
  • Multidrug resistance protein 1
  • Tumor-initiating cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells. / Lee, Yu Hsien; Yang, Hui Wen; Yang, Li Chiu; Lu, Ming Yi; Tsai, Lo Lin; Yang, Shun Fa; Huang, Yu Feng; Chou, Ming Yung; Yu, Cheng Chia; Hu, Fang Wei.

In: Oncology Letters, Vol. 14, No. 1, 2017, p. 171-179.

Research output: Contribution to journalArticle

Lee, YH, Yang, HW, Yang, LC, Lu, MY, Tsai, LL, Yang, SF, Huang, YF, Chou, MY, Yu, CC & Hu, FW 2017, 'DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells', Oncology Letters, vol. 14, no. 1, pp. 171-179. https://doi.org/10.3892/ol.2017.6132
Lee, Yu Hsien ; Yang, Hui Wen ; Yang, Li Chiu ; Lu, Ming Yi ; Tsai, Lo Lin ; Yang, Shun Fa ; Huang, Yu Feng ; Chou, Ming Yung ; Yu, Cheng Chia ; Hu, Fang Wei. / DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells. In: Oncology Letters. 2017 ; Vol. 14, No. 1. pp. 171-179.
@article{b93c4074e0e441cc9403f8debf3b95af,
title = "DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells",
abstract = "Tumor-initiating cells (TICs) are defined as a specialized subset of cells with tumor-initiating capacity that can initiate tumor growth, tumor relapse and metastasis. In the present study, osteosarcoma TICs (OS-TICs) were isolated and enriched from the osteosarcoma U2OS and MG-63 cell lines using sphere formation assays and serum-depleted media. These enriched OS-TICs showed the expression of several typical cancer stemness markers, including octamer-binding transcription factor 4, Nanog homeobox, cluster of differentiation (CD)117, Nestin and CD133, and the expression of ATP binding cassette subfamily G member 2, multidrug resistance protein 1 (MDR1) and dihydrofolate reductase (DHFR). Notably, in vitro and in vivo tumorigenic properties were enhanced in these OS-TICs. Additionally, methotrexate and doxorubicin are the most widely used anticancer agents against osteosarcoma, and the observed enhanced chemoresistance of OS-TICs to these two agents could be associated with the upregulation of DHFR and MDR1. These findings suggest that the upregulation of DHFR and MDR1 is associated with the development of chemoresistance of OS-TICs.",
keywords = "Chemo-resistance, Dihydrofolate reductase, Multidrug resistance protein 1, Tumor-initiating cells",
author = "Lee, {Yu Hsien} and Yang, {Hui Wen} and Yang, {Li Chiu} and Lu, {Ming Yi} and Tsai, {Lo Lin} and Yang, {Shun Fa} and Huang, {Yu Feng} and Chou, {Ming Yung} and Yu, {Cheng Chia} and Hu, {Fang Wei}",
year = "2017",
doi = "10.3892/ol.2017.6132",
language = "English",
volume = "14",
pages = "171--179",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells

AU - Lee, Yu Hsien

AU - Yang, Hui Wen

AU - Yang, Li Chiu

AU - Lu, Ming Yi

AU - Tsai, Lo Lin

AU - Yang, Shun Fa

AU - Huang, Yu Feng

AU - Chou, Ming Yung

AU - Yu, Cheng Chia

AU - Hu, Fang Wei

PY - 2017

Y1 - 2017

N2 - Tumor-initiating cells (TICs) are defined as a specialized subset of cells with tumor-initiating capacity that can initiate tumor growth, tumor relapse and metastasis. In the present study, osteosarcoma TICs (OS-TICs) were isolated and enriched from the osteosarcoma U2OS and MG-63 cell lines using sphere formation assays and serum-depleted media. These enriched OS-TICs showed the expression of several typical cancer stemness markers, including octamer-binding transcription factor 4, Nanog homeobox, cluster of differentiation (CD)117, Nestin and CD133, and the expression of ATP binding cassette subfamily G member 2, multidrug resistance protein 1 (MDR1) and dihydrofolate reductase (DHFR). Notably, in vitro and in vivo tumorigenic properties were enhanced in these OS-TICs. Additionally, methotrexate and doxorubicin are the most widely used anticancer agents against osteosarcoma, and the observed enhanced chemoresistance of OS-TICs to these two agents could be associated with the upregulation of DHFR and MDR1. These findings suggest that the upregulation of DHFR and MDR1 is associated with the development of chemoresistance of OS-TICs.

AB - Tumor-initiating cells (TICs) are defined as a specialized subset of cells with tumor-initiating capacity that can initiate tumor growth, tumor relapse and metastasis. In the present study, osteosarcoma TICs (OS-TICs) were isolated and enriched from the osteosarcoma U2OS and MG-63 cell lines using sphere formation assays and serum-depleted media. These enriched OS-TICs showed the expression of several typical cancer stemness markers, including octamer-binding transcription factor 4, Nanog homeobox, cluster of differentiation (CD)117, Nestin and CD133, and the expression of ATP binding cassette subfamily G member 2, multidrug resistance protein 1 (MDR1) and dihydrofolate reductase (DHFR). Notably, in vitro and in vivo tumorigenic properties were enhanced in these OS-TICs. Additionally, methotrexate and doxorubicin are the most widely used anticancer agents against osteosarcoma, and the observed enhanced chemoresistance of OS-TICs to these two agents could be associated with the upregulation of DHFR and MDR1. These findings suggest that the upregulation of DHFR and MDR1 is associated with the development of chemoresistance of OS-TICs.

KW - Chemo-resistance

KW - Dihydrofolate reductase

KW - Multidrug resistance protein 1

KW - Tumor-initiating cells

UR - http://www.scopus.com/inward/record.url?scp=85020217283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020217283&partnerID=8YFLogxK

U2 - 10.3892/ol.2017.6132

DO - 10.3892/ol.2017.6132

M3 - Article

AN - SCOPUS:85020217283

VL - 14

SP - 171

EP - 179

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 1

ER -